273 related articles for article (PubMed ID: 26030613)
1. Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease.
Shirazian S; Grant CD; Mujeeb S; Sharif S; Kumari P; Bhagat M; Mattana J
Am J Med Sci; 2015 Jun; 349(6):510-5. PubMed ID: 26030613
[TBL] [Abstract][Full Text] [Related]
2. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
[TBL] [Abstract][Full Text] [Related]
3. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
Weir MR; Lakkis JI; Jaar B; Rocco MV; Choi MJ; Kramer HJ; Ku E
Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547
[TBL] [Abstract][Full Text] [Related]
4. Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?
Yildirim T; Arici M; Piskinpasa S; Aybal-Kutlugun A; Yilmaz R; Altun B; Erdem Y; Turgan C
Ren Fail; 2012; 34(9):1095-9. PubMed ID: 22950572
[TBL] [Abstract][Full Text] [Related]
5. The effect of renin-angiotensin system blockade on renal protection in chronic kidney disease patients with hyperkalemia.
Lee JH; Kwon YE; Park JT; Lee MJ; Oh HJ; Han SH; Kang SW; Choi KH; Yoo TH
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):491-7. PubMed ID: 25143329
[TBL] [Abstract][Full Text] [Related]
6. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
7. The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.
Wetmore JB; Tang F; Sharma A; Jones PG; Spertus JA
Am Heart J; 2015 Oct; 170(4):735-43. PubMed ID: 26386797
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
9. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
St Peter WL; Odum LE; Whaley-Connell AT
Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.
Susantitaphong P; Sewaralthahab K; Balk EM; Eiam-ong S; Madias NE; Jaber BL
Am J Hypertens; 2013 Mar; 26(3):424-41. PubMed ID: 23382494
[TBL] [Abstract][Full Text] [Related]
11. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
Frimodt-Møller M; Høj Nielsen A; Strandgaard S; Kamper AL
Nephrol Dial Transplant; 2010 Mar; 25(3):842-7. PubMed ID: 19903661
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
Oh YJ; Kim SM; Shin BC; Kim HL; Chung JH; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Lee C; Jung JY
PLoS One; 2017; 12(1):e0170874. PubMed ID: 28122064
[TBL] [Abstract][Full Text] [Related]
14. Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care.
Pecoits-Filho R; Fliser D; Tu C; Zee J; Bieber B; Wong MMY; Port F; Combe C; Lopes AA; Reichel H; Narita I; Stengel B; Robinson BM; Massy Z;
J Clin Hypertens (Greenwich); 2019 Jul; 21(7):991-1001. PubMed ID: 31169352
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
Lin CC; Wu YT; Yang WC; Tsai MJ; Liu JS; Yang CY; Li SY; Ou SM; Tarng DC; Hsu CC
PLoS One; 2017; 12(12):e0189126. PubMed ID: 29216260
[TBL] [Abstract][Full Text] [Related]
16. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
[TBL] [Abstract][Full Text] [Related]
17. Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment.
Higuchi S; Kohsaka S; Shiraishi Y; Katsuki T; Nagatomo Y; Mizuno A; Sujino Y; Kohno T; Goda A; Yoshikawa T;
Eur J Intern Med; 2019 Apr; 62():58-66. PubMed ID: 30737061
[TBL] [Abstract][Full Text] [Related]
18. Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response.
Gonçalves AR; Khwaja A; Ahmed AK; El Kossi M; El Nahas M
Nephron Clin Pract; 2011; 119(4):c348-54. PubMed ID: 22135795
[TBL] [Abstract][Full Text] [Related]
19. Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients.
Karabsheh S; Verma DR; Jain M; Stoddard G; Brunisholz K; Stehlik J; Kfoury A; Gilbert E; Bader F
Am J Cardiol; 2011 Dec; 108(12):1836-9. PubMed ID: 22133132
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
Brosnahan GM; Abebe KZ; Moore CG; Bae KT; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Rahbari-Oskoui FF; Steinman TI; Torres VE; The Halt Pkd Investigators
Curr Hypertens Rev; 2018; 14(1):39-47. PubMed ID: 29564978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
